BLACK FUNGUS
COVID-19 increases black fungus infection risk in India
Mucormycosis is a rare type of fungal infection that occurs through exposure to fungi called mucormycetes. These fungi commonly occur in the environment, particularly in leaves, soil, compost, and animal dung. Mucormycetes can enter the body through breathing, inhaling, and exposed wounds in the skin.
There are
Respiratory-related symptoms include:
- cough
- fever
- headache
- chest pain
- nasal or sinus congestion and pain
- shortness of breath
Skin-related symptoms, which can occur in and spread to any part of the body, include:
- blackened skin tissue
- redness, swelling, tenderness
- blisters
- ulcers
Mucormycosis is not contagious, and most people who come in contact with the fungi do not develop an infection. However, people with severely weakened immune systems are at increased risk of mucormycosis. This includes people with:
- diabetes
- cancer
- HIV
- skin injury
- surgery
Doctors can treat the infection by administering antifungal medication or performing surgery to remove the affected area. If left untreated, mucormycosis can be fatal, with a mortality rate of 54%, according to the
- Mucormycosis, or black fungus, is a rare but serious infection that requires medication or removal surgery.
- SARS-CoV-2 infection and COVID-19 treatment make the immune system vulnerable to other infections, including black fungus.
- With the rise in black fungus cases, India faces a shortage of treatments in the face of two epidemics.
India has been facing high rates of COVID-19, with more than 27 million confirmed cases since January 2020. Also, the World Health Organization (WHO) recently announced that the B.1.617 variant of the SARS-CoV-2 virus in India is a “variant of global concern.”
Some scientists be immunocompromised.
Comments
Post a Comment